Adebrelimab trials for Pancreatic cancer

All Adebrelimab trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying Adebrelimab for Pancreatic cancer

• Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
  NCT06531278 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer
  NCT06475326 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
  NCT06427239 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Adebrelimab for Pancreatic cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.